N-[1-(4-chlorophenyl)-3-{7-oxa-4-azaspiro[2.5]octan-4-yl}-3-oxopropyl]acetamide
Structure Info
- Chemspace ID
- CSSS00138540351 (In-Stock Screening Compounds)
- CAS
- 2305447-57-6
- IUPAC Name
- N-[1-(4-chlorophenyl)-3-{7-oxa-4-azaspiro[2.5]octan-4-yl}-3-oxopropyl]acetamide
- Mol formula
- C17H21ClN2O3
- Mol weight
- 337 Da
- Catalog Number(s)
- CSC138540351, CSCR00215888841, Z2017692993, m11____9877290____217445, s_22____9877292____107332
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.11
- Heavy atoms count
- 23
- Rotatable bond count
- 4
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.529
- Polar surface area (Å)
- 59
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 1
![Chemical structure of N-[1-(4-chlorophenyl)-3-{7-oxa-4-azaspiro[2.5]octan-4-yl}-3-oxopropyl]acetamide (C17H21ClN2O3) - CSSS00138540351](/st/structure/200/3d399fa5661ef7cfc407b59d9a671946/CC%2528%253DO%2529NC%2528CC%2528%253DO%2529N1CCOCC11CC1%2529C1%253DCC%253DC%2528Cl%2529C%253DC1.png "C17H21ClN2O3")
- Zoom the structure
- CSSS00138540351
Items Overall 5 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 1 mg | 83.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 2 mg | 85.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 5 mg | 91.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 10 mg | 102.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 20 mg | 123.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 4-[3-(4-chlorophenyl)-3-acetamidopropanoyl]morpholine-3-carboxylic acid - CSSS00027661130](/st/structure/200/07e2d25b1ab364741a0fed5d107ca663/CC%2528%253DO%2529NC%2528CC%2528%253DO%2529N1CCOCC1C%2528O%2529%253DO%2529C1%253DCC%253DC%2528Cl%2529C%253DC1.png)
![Chemical structure of N-[1-(4-chlorophenyl)-3-oxo-3-(pyrrolidin-1-yl)propyl]acetamide - CSSS00026370069](/st/structure/200/b11cc83ce3239eda9a45e8cf12ff1d35/CC%2528%253DO%2529NC%2528CC%2528%253DO%2529N1CCCC1%2529C1%253DCC%253DC%2528Cl%2529C%253DC1.png)
![Chemical structure of 3-(4-chlorophenyl)-3-acetamido-N-[2-methyl-2-(morpholin-4-yl)propyl]propanamide - CSSS00026869353](/st/structure/200/ab31090ca34c645a7f9eb5b90d14ac65/CC%2528%253DO%2529NC%2528CC%2528%253DO%2529NCC%2528C%2529%2528C%2529N1CCOCC1%2529C1%253DCC%253DC%2528Cl%2529C%253DC1.png)
![Chemical structure of N-[1-(4-chlorophenyl)-3-oxo-3-(piperidin-1-yl)propyl]acetamide - CSSS00026826472](/st/structure/200/9ba35f127eae5400bc022c7303ef6259/CC%2528%253DO%2529NC%2528CC%2528%253DO%2529N1CCCCC1%2529C1%253DCC%253DC%2528Cl%2529C%253DC1.png)
![Chemical structure of N-[bis(4-chlorophenyl)methyl]-3-(4-chlorophenyl)-3-acetamido-N-methylpropanamide - CSSS03436542697](/st/structure/200/0cbd43ba3de257c233524c6109468bfa/CN%2528C%2528C1%253DCC%253DC%2528Cl%2529C%253DC1%2529C1%253DCC%253DC%2528Cl%2529C%253DC1%2529C%2528%253DO%2529CC%2528NC%2528C%2529%253DO%2529C1%253DCC%253DC%2528Cl%2529C%253DC1.png)
